Xpert

Molecular Diagnostics Market to be Worth $31.9 Billion by 2030: Grand View Research, Inc.

Retrieved on: 
Wednesday, July 5, 2023
Xpert, POC, Prevalence, NGS, COVID-19, Centrifugal micro-fluidic biochip, Infection, DSM-IV codes, USD, Microfluidics, Incidence, Acquisition, Miniaturization, Tuberculosis, Application, SAN, Roche, Cepheid variable, Cepheid (company), OTC, Diagnosis, Growth, Fungal infection, Power-on self-test, Cobas, PCR, Bloodstream infections, TMA, Pharmaceutical industry, Vaccine, Sequencing

The contraction in the market will be due to the decline in demand for molecular testing for COVID-19.

Key Points: 
  • The contraction in the market will be due to the decline in demand for molecular testing for COVID-19.
  • Read 270-page market research report, " Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location, By Technology (PCR, Sequencing, INAAT, TMA), By Application, By Region, And Segment Forecasts, 2023 - 2030 ", published by Grand View Research.
  • Molecular diagnostics plays an important role in infectious disease testing as they can yield effective and fast results.
  • Such advances are anticipated to drive the global molecular diagnostics market.

Molecular Diagnostics Market to be Worth $31.9 Billion by 2030: Grand View Research, Inc.

Retrieved on: 
Wednesday, July 5, 2023
Xpert, POC, Prevalence, NGS, COVID-19, Centrifugal micro-fluidic biochip, Infection, DSM-IV codes, USD, Microfluidics, Incidence, Acquisition, Miniaturization, Tuberculosis, Application, SAN, Roche, Cepheid variable, Cepheid (company), OTC, Diagnosis, Growth, Fungal infection, Power-on self-test, Cobas, PCR, Bloodstream infections, TMA, Pharmaceutical industry, Vaccine, Sequencing

The contraction in the market will be due to the decline in demand for molecular testing for COVID-19.

Key Points: 
  • The contraction in the market will be due to the decline in demand for molecular testing for COVID-19.
  • Read 270-page market research report, " Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location, By Technology (PCR, Sequencing, INAAT, TMA), By Application, By Region, And Segment Forecasts, 2023 - 2030 ", published by Grand View Research.
  • Molecular diagnostics plays an important role in infectious disease testing as they can yield effective and fast results.
  • Such advances are anticipated to drive the global molecular diagnostics market.

edX Debuts Two AI-Powered Learning Assistants Built on ChatGPT

Retrieved on: 
Friday, May 12, 2023
Learning, MOOC, Education, University, API, ChatGPT, Intelligence, Research, MIT, OpenAI, TWOU, 2U, Customer service, Comprehension, Knowledge, EdX, Circuit, Tutoring, Xpert, Electronics, AI

LANHAM, Md., May 12, 2023 /PRNewswire/ -- edX, a leading global online learning platform from 2U, Inc. (Nasdaq: TWOU), today announced the debut of two AI-powered innovations: the new edX plugin for ChatGPT and edX Xpert, an AI-powered learning assistant on the edX platform. Both tools leverage the technology of AI research and deployment company OpenAI to deliver real-time academic support and course discovery to help learners achieve their goals.

Key Points: 
  • LANHAM, Md., May 12, 2023 /PRNewswire/ -- edX , a leading global online learning platform from 2U, Inc. (Nasdaq: TWOU), today announced the debut of two AI-powered innovations: the new edX plugin for ChatGPT and edX Xpert, an AI-powered learning assistant on the edX platform.
  • The edX ChatGPT plugin is part of the initial wave of plugins available for ChatGPT Plus users.
  • Also debuting today is edX Xpert, an AI-powered learning assistant embedded in the edX platform.
  • This allows learners to quickly identify relevant content for learning, reviewing, or reinforcing concepts, helping to maximize the time they spend learning on the platform.

Cepheid Receives Emergency Use Authorization from FDA for Xpert® Mpox

Retrieved on: 
Tuesday, February 14, 2023
World Health Organization, Certificate, Monkeypox virus, Cepheid (company), COC, EVP, PCR, Diagnosis, Cor, Measles, POC, Simplex, Human, Cedillo v. Secretary of Health and Human Services, Syphilis, Infection, Chickenpox, Cow, Fever, EUA, COA, Medical device, Vaccine, Xpert, Cepheid variable

SUNNYVALE, Calif., Feb. 14, 2023 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration for Xpert Mpox, which runs on Cepheid's GeneXpert® systems. The EUA is supported by the Secretary of Health and Human Service's declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for the detection and/or diagnosis of infection with the monkeypox virus.

Key Points: 
  • SUNNYVALE, Calif., Feb. 14, 2023 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration for Xpert Mpox, which runs on Cepheid's GeneXpert® systems.
  • Xpert Mpox is authorized for use in moderately complex settings and is considered authorized for use in point of care (POC) settings under the EUA for use on GeneXpert Xpress systems.
  • "Thankfully, the threat of mpox in the United States has decreased dramatically since last summer.
  • The World Health Organization recommends that suspected cases of mpox be confirmed with a PCR test run on an appropriate human lesion sample1.